Mark S Shearman - Net Worth and Insider Trading
Mark S Shearman Net Worth
The estimated net worth of Mark S Shearman is at least $367,786 dollars as of 2024-05-17. Mark S Shearman is the EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine Inc and owns about 65,559 shares of Editas Medicine Inc (EDIT) stock worth over $367,786. Mark S Shearman is also the Chief Scientific Officer of Applied Genetic Technologies Corp and owns about 0 shares of Applied Genetic Technologies Corp (AGTC) stock worth over $0. Details can be seen in Mark S Shearman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark S Shearman has not made any transactions after 2023-02-13 and currently still holds the listed stock(s).
Transaction Summary of Mark S Shearman
Mark S Shearman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark S Shearman owns 2 companies in total, including Applied Genetic Technologies Corp (AGTC) , and Editas Medicine Inc (EDIT) .
Click here to see the complete history of Mark S Shearman’s form 4 insider trades.
Insider Ownership Summary of Mark S Shearman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGTC | Applied Genetic Technologies Corp | 2018-12-14 | Chief Scientific Officer |
| EDIT | Editas Medicine Inc | 2023-02-13 | EVP & Chief Scientific Officer |
Mark S Shearman Latest Holdings Summary
Mark S Shearman currently owns a total of 2 stocks. Among these stocks, Mark S Shearman owns 65,559 shares of Editas Medicine Inc (EDIT) as of February 13, 2023, with a value of $367,786 and a weighting of 100%. Mark S Shearman also owns 0 shares of Applied Genetic Technologies Corp (AGTC) as of December 14, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Mark S Shearman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EDIT | Editas Medicine Inc | 2023-02-13 | 65,559 | 5.61 | 367,786 |
| AGTC | Applied Genetic Technologies Corp | 2018-12-14 | 0 | 0.39 | 0 |
Holding Weightings of Mark S Shearman
Mark S Shearman Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark S Shearman has made a total of 2 transactions in Editas Medicine Inc (EDIT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Editas Medicine Inc is the sale of 2,790 shares on February 13, 2023, which brought Mark S Shearman around $26,979.
According to the SEC Form 4 filings, Mark S Shearman has made a total of 0 transactions in Applied Genetic Technologies Corp (AGTC) over the past 5 years. The most-recent trade in Applied Genetic Technologies Corp is the sale of 3,000 shares on December 14, 2018, which brought Mark S Shearman around $10,050.
Insider Trading History of Mark S Shearman
- 1
Mark S Shearman Trading Performance
GuruFocus tracks the stock performance after each of Mark S Shearman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark S Shearman is 6.86%. GuruFocus also compares Mark S Shearman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark S Shearman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark S Shearman's insider trading performs compared to the benchmark.
Performance of Mark S Shearman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.2 | | | | | |
| Relative Return to S&P 500(%) | -5.55 | | | | | |
Mark S Shearman Ownership Network
Mark S Shearman Owned Company Details
What does Applied Genetic Technologies Corp do?
Who are the key executives at Applied Genetic Technologies Corp?
Mark S Shearman is the Chief Scientific Officer of Applied Genetic Technologies Corp. Other key executives at Applied Genetic Technologies Corp include Chief Medical Officer Susan Schneider , Chief Financial Officer Jonathan I Lieber , and See Remarks Stephen W Potter .
Applied Genetic Technologies Corp (AGTC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Applied Genetic Technologies Corp (AGTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Applied Genetic Technologies Corp (AGTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Applied Genetic Technologies Corp (AGTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Applied Genetic Technologies Corp Insider Transactions
Mark S Shearman Mailing Address
Above is the net worth, insider trading, and ownership report for Mark S Shearman. You might contact Mark S Shearman via mailing address: C/o Applied Genetic Technologies Corp, 11801 Research Drive, Suite D, Alachua Fl 32615.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
